In this personal essay, hairstylist and curl expert Kys Clark shares how having alopecia has redefined what beauty means to ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Leqselvi ™ (deuruxolitinib) is now available for the treatment of adults with severe alopecia areata.

Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

New study in Stem Cell Research & Therapy reveals biological pathways behind hair loss, potential new treatments.

Sun Pharmaceutical Industries Limited announced Leqselvi (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the US. Leqselvi is ...

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...

The delay in Sun Pharma's launch of Leqselvi in the US was caused by a patent infringement case, which was later settled in a ...

As part of the agreement, Incyte has granted Sun Pharma a limited, non-exclusive license to US Patent Nos. 9,662,335 and ...

Mumbai: Sun Pharmaceutical Industries Limited has announced the launch of LEQSELVI (deuruxolitinib) 8 mg tablets in the U.S.

"The launch of LEQSELVI in the U.S. brings an effective, new treatment option for severe alopecia areata to eligible patients and the healthcare providers who treat them," said Richard Ascroft, CEO, ...